Sanford, D., Kantarjian, H., Skinner, J., Jabbour, E., & Cortes, J. (2015). Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor. Haematologica.
Citação norma ChicagoSanford, David, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, and Jorge Cortes. "Phase II Trial of Ponatinib in Patients With Chronic Myeloid Leukemia Resistant to One Previous Tyrosine Kinase Inhibitor." Haematologica 2015.
Citação norma MLASanford, David, et al. "Phase II Trial of Ponatinib in Patients With Chronic Myeloid Leukemia Resistant to One Previous Tyrosine Kinase Inhibitor." Haematologica 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.